NEW YORK, March 21, 2023 /PRNewswire/ The global leukapheresis market size will be USD 136.3 million by 2030, growing at a 8.4% CAGR during this decade, according to P&S Intelligence. This
The development of the COVID-19 vaccine market will depend on several tough-to-predict outcomes, like the duration of vaccine protection, how variants evolve, and how competitors progress.
Despite the early lead that Moderna (MRNA) and BioNTech (BNTX) hold, and their clear dominance in the pandemic market for COVID-19 vaccine sales, we re not yet convinced that COVID-19 will require widespread annual booster shots, and if so, whether these companies will remain dominant in the long run.
Still, we do expect these mRNA companies to dominate the global COVID-19 vaccine market in the short term, particularly as third-dose boosters become available late in 2021. We expect 41% of delivered doses in 2022 to be based on mRNA technology.